Clinical studies showed that in the treatment of cachexia, quinolones, the recent treatment of patients with chronic diseases including CHF, exploited similar signaling pathways in humans to that of ghrelin-GHSR, which provides a crucial clue in the study of ghrelin-GHSR-dependent therapeutic targets [97]. The gene discussed is GHSR; the disease is congestive heart failure.